Intrinsic responses to Borna disease virus infection of the central nervous system.

Immune cells invading the central nervous system (CNS) in response to Borna disease virus (BDV) antigens are central to the pathogenesis of Borna disease (BD). We speculate that the response of the resident cells of the brain to infection may be involved in the sensitization and recruitment of these inflammatory cells. To separate the responses of resident cells from those of cells infiltrating from the periphery, we used dexamethasone to inhibit inflammatory reactions in BD. Treatment with dexamethasone prevented the development of clinical signs of BD, and the brains of treated animals showed no neuropathological lesions and a virtual absence of markers of inflammation, cell infiltration, or activation normally seen in the CNS of BDV-infected rats. In contrast, treatment with dexamethasone exacerbated the expression of BDV RNA, which was paralleled by a similarly elevated expression of mRNAs for egr-1, c-fos, and c-jun. Furthermore, dexamethasone failed to inhibit the increase in expression of mRNAs for tumor necrosis factor alpha, macrophage inflammatory protein 1 beta, interleukin 6, and mob-1, which occurs in the CNS of animals infected with BDV. Our findings suggest that these genes, encoding transcription factors, chemokines, and proinflammatory cytokines, might be directly activated in CNS resident cells by BDV. This result supports the hypothesis that the initial phase of the inflammatory response to BDV infection in the brain may be dependent upon virus-induced activation of CNS resident cells.

[1]  A. Baldwin,et al.  Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.

[2]  A. Pardee,et al.  Ras activation of genes: Mob-1 as a model. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Baggiolini,et al.  CC chemokines in allergic inflammation. , 1994, Immunology today.

[4]  J. Farber,et al.  IFN and virus-inducible expression of an immediate early gene, crg-2/IP-10, and a delayed gene, I-A alpha in astrocytes and microglia. , 1994, Journal of immunology.

[5]  H. Vliagoftis,et al.  Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination , 1993, Neuroscience.

[6]  C. Saper,et al.  Distribution and characterization of tumor necrosis factor‐α‐like immunoreactivity in the murine central nervous system , 1993 .

[7]  Z. Fu,et al.  Differential effects of rabies and borna disease viruses on immediate-early- and late-response gene expression in brain tissues , 1993, Journal of virology.

[8]  D. Kaplan,et al.  Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells , 1993, Neuron.

[9]  D. Taub,et al.  Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells , 1993, The Journal of experimental medicine.

[10]  M. A. McClure,et al.  Sequence similarity between Borna disease virus p40 and a duplicated domain within the paramyxovirus and rhabdovirus polymerase proteins , 1992, Journal of virology.

[11]  C. Nathan,et al.  Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  H. Koprowski,et al.  Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus , 1992, Journal of virology.

[13]  L. Stitz,et al.  [Immunopathogenesis of Borna disease]. , 1991, Tierarztliche Praxis.

[14]  E. Weihe,et al.  The neuro-B cell link of peptidergic innervation in the Bursa Fabricii , 1991, Brain, Behavior, and Immunity.

[15]  E. Weihe,et al.  Interrelation of peptidergic innervation with mast cells and ED1-positive cells in rat thymus , 1991, Brain, Behavior, and Immunity.

[16]  W. Herzog,et al.  Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells. , 1991, Journal of immunology.

[17]  L. Stitz,et al.  Borna disease virus-induced meningoencephalomyelitis caused by a virus-specific CD4+ T cell-mediated immune reaction. , 1990, The Journal of general virology.

[18]  M. Karin,et al.  Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction , 1990, Cell.

[19]  M. Muramatsu,et al.  Structure and expression of the rat c-jun messenger RNA: tissue distribution and increase during chemical hepatocarcinogenesis. , 1989, Cancer research.

[20]  T. Curran,et al.  Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modification in vitro. , 1987, Oncogene.

[21]  T. Shenk,et al.  Impact of virus infection on host cell protein synthesis. , 1987, Annual review of biochemistry.

[22]  N. Kitamura,et al.  Primary structures of the mRNAs encoding the rat precursors for bradykinin and T-kinin. Structural relationship of kininogens with major acute phase protein and alpha 1-cysteine proteinase inhibitor. , 1985, The Journal of biological chemistry.

[23]  T. Kao,et al.  Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. , 1985, Nucleic acids research.

[24]  M. Oldstone,et al.  Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo , 1984, Journal of virology.

[25]  O. Narayan,et al.  Pathogenesis of Borna disease in rats: immune-mediated viral ophthalmoencephalopathy causing blindness and behavioral abnormalities. , 1983, The Journal of infectious diseases.

[26]  R. Zinkernagel,et al.  Inflammatory process in murine lymphocytic choriomeningitis is maximal in H-2K or H-2D compatible interactions. , 1976, Journal of immunology.

[27]  A. Fauci,et al.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations. , 1976, Annals of internal medicine.